Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.52 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | SELL | P14151 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | SELE | P16581 | 1/20 | 0.46 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12430315 | 0.93 | AMY1A (0.61) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL15080879 | 0.91 | SHBG (0.45) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL1023654 | 0.89 | DHFR (0.45) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL30576381 | 0.87 | ALDH1A1 (0.48) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL8897253 | 0.87 | GABRA1 (0.41) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL5680640 | 0.87 | SELL (0.59) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL1021767 | 0.87 | ALDH1A1 (0.48) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL14997933 | 0.87 | GABRA1 (0.41) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL22408778 | 0.87 | DHFR (0.50) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 | |
| SCHEMBL14606502 | 0.85 | AMY1A (0.53) | GABRA1GABRB2AMY1ACYP2C9SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116751106-A | Refining method of 2, 6-diethyl-4-methyl bromobenzene | 江苏省农用激素工程技术研究中心有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-108264449-B | Preparation method of 2, 6-diethyl-4-methylphenol | 浙江省诸暨合力化学对外贸易有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-107577120-B | Resist stripping liquid composition, display substrate and manufacturing method thereof | 东友精细化工有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-108264449-A | A kind of preparation method of 2,6- diethyl -4- methylphenols | 浙江省诸暨合力化学对外贸易有限公司 | 2018-07-10 | — | — | CN | claimed |
| CN-107577120-A | Anticorrosive additive stripping liquid controlling composition, display base plate and its manufacture method | 东友精细化工有限公司 | 2018-01-12 | — | — | CN | claimed |
| JP-58211146-A | — | — | None | — | — | JP | disclosed |
| US-12559458-B2 | Co-crystals or salts of psilocin and methods of treatment therewith | Reset Pharmaceuticals, Inc. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250145795-A1 | OLEFIN/SILANE INTERPOLYMER COMPOSITIONS WITH EXCELLENT THERMAL OXIDATION RESISTANCE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-05-08 | — | — | US | disclosed |
| US-20250125075-A1 | PROCESS FOR PRODUCING CABLE WITH INSULATION LAYER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-04-17 | — | — | US | disclosed |
| EP-4486448-A1 | CO-CRYSTALS OR SALTS COMPRISING PSILOCIN | Reset Pharmaceuticals, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| US-20240425448-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-12-26 | — | — | US | disclosed |
| US-20240383849-A1 | CO-CRYSTAL OR SALT | Reset Pharmaceuticals, Inc. | 2024-11-21 | — | — | US | disclosed |
| EP-0422535-B1 | Polymerisable perylene-3,4,9,10-tetracarboxylic diimides and polymeric products thereof | BASF AG (DE) | 1994-03-02 | — | — | EP | disclosed |
| EP-0432445-B1 | FLUORESCENT PRINTING INK | BASF Lacke + Farben AG (DE) | 1993-06-02 | — | — | EP | disclosed |
| EP-0432445-A2 | Fluorescent printing ink | BASF Lacke + Farben AG (DE) | 1991-06-19 | — | — | EP | disclosed |
| EP-0422474-A2 | Fluorescent pigments | BASF Aktiengesellschaft (DE) | 1991-04-17 | — | — | EP | disclosed |
| EP-0422535-A1 | Polymerisable perylene-3,4,9,10-tetracarboxylic diimides and polymeric products thereof | BASF Aktiengesellschaft (DE) | 1991-04-17 | — | — | EP | disclosed |
| JP-S58211146-A | DEVELOPING SOLUTION USED FOR DIAZO COPYING | RICOH CO LTD | 1983-12-08 | — | — | JP | disclosed |
| US-3979309-A | Lubricating oil additive | UOP INC. (US) | 1976-09-07 | — | — | US | disclosed |
| US-3933924-A | Process for preparing hydroxydiphenyl | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383849-A1 | CO-CRYSTAL OR SALT | SLC6A3, SLC6A2, OPRK1 | GABRA1 3898/4885GABRB2 3840/4885AMY1A 2968/4885 |
| US-12559458-B2 | Co-crystals or salts of psilocin and methods of treatment therewith | SLC6A2, SLC6A4, SLC6A3 | GABRA1 4197/4885GABRB2 3835/4885AMY1A 1745/4885 |
| US-20240425448-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION | IDH3A, CA7, C9 | GABRA1 3159/4885GABRB2 3492/4885AMY1A 1288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.